CYP 12.5% 27.0¢ cynata therapeutics limited

Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-169

  1. 211 Posts.
    lightbulb Created with Sketch. 23
    This is great news @pfeifer1982

    I like how you can compare the changes to the trial over time via a side by side comparison (see link below)

    https://clinicaltrials.gov/ct2/history/NCT04537351?A=3&B=4&C=Side-by-Side#StudyPageTop

    Quite a big change looking at all the updates and recruitment centers.

    Looking at a chart of the incidence of ARDS in the general population (below), a rate of about 15 per 100,000 seems quite common.

    Recruitment shouldn't take too long now, can't wait to see the results! especially after seeing the positive clinical trial results coming out from other similar trials (and more results to come soon).

    https://hotcopper.com.au/data/attachments/3201/3201974-c5c602527efc8959c7d670908d3e27d6.jpg



 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
0.030(12.5%)
Mkt cap ! $48.50M
Open High Low Value Volume
26.0¢ 29.5¢ 26.0¢ $113.1K 420.4K

Buyers (Bids)

No. Vol. Price($)
1 4999 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 3935 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.